A detailed history of Twin Tree Management, LP transactions in Biogen Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 13,000 shares of BIIB stock, worth $1.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,000
Previous 1,737 648.42%
Holding current value
$1.9 Million
Previous $402,000 526.62%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $483,830 - $605,971
2,559 Added 147.32%
4,296 $832,000
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $330,933 - $411,182
1,737 New
1,737 $402,000
Q2 2023

Aug 11, 2023

BUY
$275.25 - $318.06 $2.73 Million - $3.15 Million
9,913 Added 50.48%
29,552 $8.42 Million
Q1 2023

May 10, 2023

SELL
$256.56 - $292.34 $7.33 Million - $8.35 Million
-28,557 Reduced 59.25%
19,639 $5.46 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $16.6 Million - $20.1 Million
-65,616 Reduced 57.65%
48,196 $13.3 Million
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $3.35 Million - $4.62 Million
17,208 Added 17.81%
113,812 $30.4 Million
Q2 2022

Aug 11, 2022

BUY
$187.54 - $223.02 $7.05 Million - $8.39 Million
37,607 Added 63.74%
96,604 $19.7 Million
Q1 2022

May 11, 2022

BUY
$193.77 - $244.14 $8.96 Million - $11.3 Million
46,220 Added 361.74%
58,997 $12.4 Million
Q2 2021

Aug 12, 2021

SELL
$259.0 - $414.71 $22.4 Million - $35.9 Million
-86,648 Reduced 87.15%
12,777 $4.42 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $11.5 Million - $13.5 Million
47,309 Added 90.78%
99,425 $27.8 Million
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $4.29 Million - $6.46 Million
-18,162 Reduced 25.84%
52,116 $12.8 Million
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $5.1 Million - $5.89 Million
19,261 Added 37.75%
70,278 $19.9 Million
Q2 2020

Aug 12, 2020

BUY
$258.66 - $342.55 $7.2 Million - $9.53 Million
27,831 Added 120.03%
51,017 $13.7 Million
Q1 2020

May 13, 2020

SELL
$268.85 - $341.04 $7.83 Million - $9.94 Million
-29,137 Reduced 55.69%
23,186 $7.34 Million
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $6.47 Million - $8.94 Million
29,416 Added 128.41%
52,323 $15.5 Million
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $517,724 - $580,678
-2,381 Reduced 9.42%
22,907 $5.33 Million
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $1.8 Million - $1.99 Million
-8,214 Reduced 24.52%
25,288 $5.91 Million
Q1 2019

May 10, 2019

SELL
$216.71 - $338.96 $143,895 - $225,069
-664 Reduced 1.94%
33,502 $7.92 Million
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $9.32 Million - $11.8 Million
33,464 Added 4766.95%
34,166 $10.3 Million
Q3 2018

Nov 09, 2018

SELL
$293.51 - $383.83 $7.32 Million - $9.57 Million
-24,944 Reduced 97.26%
702 $248,000
Q2 2018

Aug 08, 2018

SELL
$257.52 - $306.91 $4.27 Million - $5.08 Million
-16,563 Reduced 39.24%
25,646 $7.44 Million
Q1 2018

May 09, 2018

BUY
$260.13 - $367.91 $9.12 Million - $12.9 Million
35,057 Added 490.17%
42,209 $11.6 Million
Q4 2017

Feb 09, 2018

BUY
$307.64 - $344.58 $2.2 Million - $2.46 Million
7,152
7,152 $2.28 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.